Primary Care 2030: Creating an Enabling Ecosystem for Disruptive Primary Care Models to Achieve Universal Health Coverage in Low- and Middle-Income Countries.


Journal

Annals of global health
ISSN: 2214-9996
Titre abrégé: Ann Glob Health
Pays: United States
ID NLM: 101620864

Informations de publication

Date de publication:
03 02 2020
Historique:
entrez: 18 2 2020
pubmed: 18 2 2020
medline: 23 2 2021
Statut: epublish

Résumé

Forty years after Alma Ata, there is renewed commitment to strengthen primary health care as a foundation for achieving universal health coverage, but there is limited consensus on how to build strong primary health care systems to achieve these goals. We convened a diverse group of global stakeholders for a high-level dialogue on how to create an enabling ecosystem for disruptive primary care innovation. We focused our discussion on four themes: workforce innovation and strengthening; impactful use of data and technology; private sector engagement; and innovative financing mechanisms. Here, we present a summary of our convening's proceedings, with specific recommendations for strengthening primary health care systems within each of these four domains. In the wake of the Astana Declaration, there is global consensus that high-quality primary health care must be the foundation for universal health coverage. Significant disruptive innovation will be required to realize this goal. We offer our recommendations to the global community to catalyze further discourse and inform policy-making and program development on the path to Health for All by 2030.

Sections du résumé

Background
Forty years after Alma Ata, there is renewed commitment to strengthen primary health care as a foundation for achieving universal health coverage, but there is limited consensus on how to build strong primary health care systems to achieve these goals.
Methods
We convened a diverse group of global stakeholders for a high-level dialogue on how to create an enabling ecosystem for disruptive primary care innovation. We focused our discussion on four themes: workforce innovation and strengthening; impactful use of data and technology; private sector engagement; and innovative financing mechanisms.
Findings
Here, we present a summary of our convening's proceedings, with specific recommendations for strengthening primary health care systems within each of these four domains.
Conclusions
In the wake of the Astana Declaration, there is global consensus that high-quality primary health care must be the foundation for universal health coverage. Significant disruptive innovation will be required to realize this goal. We offer our recommendations to the global community to catalyze further discourse and inform policy-making and program development on the path to Health for All by 2030.

Identifiants

pubmed: 32064227
doi: 10.5334/aogh.2471
pmc: PMC7006582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9

Informations de copyright

Copyright: © 2020 The Author(s).

Déclaration de conflit d'intérêts

Darren Back declares a conflict of interest of being employed by the pharmaceutical company Pfizer Inc. No other authors have conflicts of interest to disclose.

Références

J Health Care Poor Underserved. 2019;30(2):456-467
pubmed: 31130530
BMJ Glob Health. 2018 Oct 2;3(Suppl 3):e001020
pubmed: 30305941
J Gen Intern Med. 2017 May;32(5):566-571
pubmed: 27943038
BMJ. 2018 May 21;361:k1716
pubmed: 29784870
Lancet. 2018 Nov 3;392(10158):1605-1607
pubmed: 30496065
Inform Prim Care. 2008;16(2):139-45
pubmed: 18713530
Reprod Health. 2016 Sep 30;13(Suppl 2):107
pubmed: 27719680
Lancet. 2019 Jul 27;394(10195):345-356
pubmed: 31303318
Lancet. 2017 Jul 8;390(10090):e19-e20
pubmed: 28651883
Lancet. 2016 Jun 18;387(10037):2482-4
pubmed: 27086171
Hum Resour Health. 2018 Aug 16;16(1):39
pubmed: 30115074
J Am Board Fam Pract. 2005 Jul-Aug;18(4):297-303
pubmed: 15994475
Science. 2018 Aug 24;361(6404):
pubmed: 30139847
BMJ Glob Health. 2019 Oct 23;4(5):e001790
pubmed: 31749996

Auteurs

Dan Schwarz (D)

Harvard Medical School, Program in Global Primary Care and Social Change, Boston, US.
Ariadne Labs at Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health, Boston, US.

David Duong (D)

Harvard Medical School, Program in Global Primary Care and Social Change, Boston, US.

Chase Adam (C)

Watsi, San Francisco, US.

J K Awoonor-Williams (JK)

Ghana Health Services, Policy, Planning, Monitoring and Evaluation, Accra, GH.

Darren Back (D)

Pfizer Inc., Social Investments and Corporate Responsibility, New York, US.

Abhay Bang (A)

Society for Education, Action and Research in Community Health (SEARCH), Gadchiroli, Nagpur, IN.

Rani Bang (R)

Society for Education, Action and Research in Community Health (SEARCH), Gadchiroli, Nagpur, IN.

Madeleine Beebe (M)

Muso, Bamako, ML.

Shreya Bhatt (S)

Medic Mobile, Mumbai, IN.

John Campbell (J)

Results for Development, Washington, DC, US.

Magnus Conteh (M)

Last Mile Health Inc., Community Health Academy, Boston, US.

Dessislava Dimitrova (D)

World Economic Forum, Geneva, CH.

Donika Dimovska (D)

Results for Development, Washington, DC, US.

Jean-Paul Dossou (JP)

Centre de recherche en Reproduction Humaine et en Démographie, Public Health, BJ.
Instituut voor Tropische Geneeskunde, Public Health, Antwerpen, BE.

Timothy Evans (T)

The World Bank Group, Health, Nutrition and Population Global Practice, Washington, DC, US.

Mazin Gadir (M)

Dubai Health Authority, Executive Office for Organizational Transformation, Dubai, AE.

Khaleda Islam (K)

Health Services of Bangladesh, BD.

Ronald Kasyaba (R)

Uganda Catholic Medical Bureau, Kampala, UG.

Priya Kumar (P)

Watsi, San Francisco, US.

Catherine Levy (C)

Sanofi SA, Global Health Programs for Non Communicable Diseases, Paris, FR.

Tran Mai Oanh (TM)

Health Strategy and Policy Institute, Department of Public Health, Hanoi, VN.

Nahed Monsef (N)

Dubai Health Authority, Department of Health Affairs, Dubai, AE.

Juhwan Oh (J)

Seoul National University College of Medicine, JW LEE Center for Global Medicine, Seoul, KR.

Nathaniel Otoo (N)

Results for Development, Washington, DC, US.

Daniel Palazuelos (D)

Harvard Medical School, Department of Global Health and Social Medicine, Boston, US.
Partners In Health, Boston, US.

Andy Poh (A)

United Arab Emirates Prime Minister's Office, Dubai, AE.

Sylvana Sinha (S)

Praava Health, BD.

Catharine Smith (C)

Harvard Medical School, Center for Primary Care, Boston, US.

Ben Stewart (B)

F Hoffmann-La Roche AG, Foundation Medicine, Basel, CH.

Cicely Thomas (C)

Results for Development, Washington, DC, US.

Beth Tritter (B)

Primary Health Care Performance Initiative, Washington, DC, US.

Peter Varnum (P)

World Economic Forum, Global Health and Healthcare, Geneva, CH.

Taylor Weilnau (T)

Harvard Medical School, Center for Primary Care, Boston, US.

Andrew Ellner (A)

Harvard Medical School, Program in Global Primary Care and Social Change, Boston, US.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH